CLOVIS ONCOLOGY INC (NASDAQ:CLVS)

Why Clovis Bladder Cancer Treatment Rucaparib Is in Big Trouble

Posted: April 15, 2019 at 10:40 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares dropped on Monday after the firm announced that it would be halting its midstage trial testing its lead drug in bladder cancer patients. Management ...
Read Full Story »

Clovis Oncology Wins Big With European Patent

Posted: December 4, 2018 at 10:05 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares jumped early Tuesday after the European Patent Office upheld the company’s claims. Specifically, the European Patent Office upheld claims of European Patent 2534153 in ...
Read Full Story »

IBM, General Electric Drop into Wednesday’s 52-Week Low Club

Posted: October 31, 2018 at 3:45 pm

October 31, 2018: Here are four stocks trading with heavy volume among 159 equities making new 52-week lows by late afternoon on Wednesday. On the NYSE advancers lead decliners by ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More

Posted: October 31, 2018 at 9:05 am

Stocks were indicated to open much higher on Wednesday after Tuesday's bounce, and earnings may be saving the day, on top of a strong ADP payrolls report. Some investors have ...
Read Full Story »

Keycorp, eBay Drop Into Monday’s 52-Week Low Club

Posted: October 22, 2018 at 2:00 pm

October 22, 2018: Here are four stocks trading with heavy volume among 413 equities making new 52-week lows by midday Monday. On the New York Stock Exchange, decliners lead advancers ...
Read Full Story »

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Posted: October 19, 2018 at 10:10 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares dropped on Friday after the company announced initial data from its Phase 2 TRITON2 clinical trial of Rubraca at the ESMO 2018 Congress of ...
Read Full Story »

Clovis Wins Big With FDA Update

Posted: October 2, 2018 at 12:10 pm

Clovis Oncology Inc. (NASDAQ: CLVS) shares jumped on Tuesday after the U.S. Food and Drug Administration (FDA) gave a critical update. The FDA granted Breakthrough Therapy designation for Rubraca (rucaparib) ...
Read Full Story »

Clovis Finally Faces the Music for Fraudulent Lung Cancer Drug Results

Posted: September 19, 2018 at 1:00 pm

Clovis Oncology Inc. (NASDAQ: CLVS) shares might not be showing it now, but the company is facing some heat from the U.S. Securities and Exchange Commission (SEC). The company, its ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Posted: September 11, 2018 at 10:55 am

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

Clovis Breaks Into Europe With EMA Validation

Posted: July 5, 2018 at 8:55 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares saw a bump early on Thursday after the company announced that the European Medicines Agency (EMA) has validated its application for a Type 2 ...
Read Full Story »

3 Stocks to Buy Now With Up to 100% or More Upside Potential

Posted: April 11, 2018 at 8:10 am

One reason that investors continue to do business with full-service brokerage firms is they generate investment ideas, and when they make a call, they typically have solid reasons and a ...
Read Full Story »

Analyst Has 4 Favorite Biotechnology Stocks to Buy Now

Posted: March 15, 2018 at 9:40 am

Biotechnology tends to have very strong up and down moves, and last year the industry reversed the down momentum that started in 2015 and actually outperformed the S&P 500. Many ...
Read Full Story »

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Posted: March 8, 2018 at 11:50 am

Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Best Buy, Chipotle, Exact Sciences, Fitbit, Itron, NuVasive, Palo Alto Networks, Stryker and More

Posted: February 27, 2018 at 9:15 am

Stocks have recovered much of their losses since the sell-off began at the end of January. That being said, there are still roughly 1,000 points on the Dow and roughly ...
Read Full Story »

Jefferies Has Top Health Care Stocks to Buy as Sector Explodes

Posted: October 25, 2017 at 8:15 am

During 2015 and last year as the brutal presidential campaign played out, the health care sector, and especially the drugmakers, became one of the favorite whipping boys for the candidates, ...
Read Full Story »